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Introduction: Limited resources in low- and middle-income countries (LMICs) drive tremendous innovation in
medicine, as well as in other fields. It is not often recognized that several important surgical tools and methods,
widely used in high-income countries, have their origins in LMICs. Surgical care around the world stands much to
gain from these innovations. In this paper, we provide a short review of some of these succesful innovations and
their origins that have had an important impact in healthcare delivery worldwide.
Review: Examples of LMIC innovations that have been adapted in high-income countries include the Bogotá bag
for temporary abdominal wound closure, the orthopaedic external fixator for complex fractures, a hydrocephalus
fluid valve for normal pressure hydrocephalus, and intra-ocular lens and manual small incision cataract surgery. LMIC
innovations that have had tremendous potential global impact include mosquito net mesh for inguinal hernia
repair, and a flutter valve for intercostal drainage of pneumothorax.
Conclusion: Surgical innovations from LMICs have been shown to have comparable outcomes at a fraction of the
cost of tools used in high-income countries. These innovations have the potential to revolutionize global surgical
care. Advocates should actively seek out these innovations, campaign for the financial gains from these innovations
to benefit their originators and their countries, and find ways to develop and distribute them locally as well as
globally.
Keywords: Global surgery, Essential surgery, Value innovation, Surgical technology, External fixator, Laparostomy,
Ventriculo-peritoneal shunt, Mesh hernia repair, Intra-ocular lens, Flutter valveBackground
Limited human and physical resources in low- and middle-
income countries drive tremendous innovation. Reverse
innovation, first popularized by Vijay Govindarajan and
Chris Trimble in the business world [1], describes innova-
tions that were originally developed and used in LMICs
but later ‘trickled up’ to richer countries. We prefer to use
the term ‘value’ innovation, since ‘reverse’ or ‘bottom up’
innovation may belie the importance and quality of these
types of innovations. ‘Reverse’ also implies that the natural
flow of innovation should be from high to low income
settings and suggests that it is unnatural for innovation to
emerge from resource- constrained settings. An alternative
term may be “cost-efficient innovation”. The essential truth
is that these innovations are as good, if not better, in* Correspondence: mikeytha@gmail.com
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reproduction in any medium, provided the ordealing with the task at hand, but come at a fraction of the
cost, hence providing tremendous value.
The impetus for the development of low-cost, quality
innovation in LMICs is an acute need in the local setting,
not the potential for export back to rich countries. Yet, the
need for low-cost high-quality innovation in medicine
knows no borders. Bismarck implied that the turmoil,
scarce resources and high demands of war produce innova-
tions of lasting value when he said, “Krieg ist der Vater alle
Dinge” (War is the Father of All Things). Scarce human
and physical resources in many LMICs in the face of dire
need have also driven tremendous innovation without
sacrificing efficacy. Mounting medical costs around the
world urgently demand that we search for value innovation
everywhere.
Surgical tools, in particular, have benefited from the
creative intelligence of physicians practicing with limited
resources around the world. There have been several
surgical innovations, now standard therapy worldwide,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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detail some of these surgical innovations, their origins,
applicability to high-income settings, and their realized




In 1984, Dr. Oswaldo Borraez was a second year surgical
resident at the Hospital San Juan de Dios in the poorest
areas of Bogotá, Colombia. He was assisting at a laparot-
omy for a patient who had a serious abdominal infection,
precluding closure. Spotting a three-liter polyethylene
urine bag, he suggested its use to close the abdomen as an
interim measure. The bag was attached temporarily to the
edges of the patient’s abdominal wound and functioned as
a patch over the large laparostomy until, at a later time,
the abdomen could be formally closed. Previous utlization
of other substances for this purpose, such as sterile towels,
was known to increase infection rates. The experiment
worked; no infection ensued, the transparent bag allowed
for direct visual monitoring of the abdominal contents
and the bag itself proved to be strong and resilient, yet
flexible [2]. An American trauma surgeon, after visiting
Colombia and learning of the technique, wrote about the
innovation and after numerous studies validating its
efficacy [3,4], it soon became popular owing to its obvious
simplicity [5,6]. The subsequent addition of low-grade
suction improved its efficacy [7]. This method is now a
recommended technique for the management of an open
abdomen [8]. In 1999, it was found that 25% of surgeons
used the Bogotá bag as their preferred method of tempor-
ary abdominal closure, being the most common technique
for leaving an abdomen open at the time [9]. A 3-liter
intravenous infusion “Bogotá” bag costs well under US$5,
while polypropylene vacuum bags and synthetic, absorbable
meshes depending on their size can cost from US$153
to US$1600 [10]. This simple, highly efficient and cost-
effective method of managing complex abdominal injuries,
wounds and infections has helped thousands of trauma
patients globally. It has been the starting-point for the
development of newer, more sophisticated, devices.
Orthopaedic external fixator
Dr Gavril Abramovich Ilizarov was an orthopedic surgeon
who trained in Crimea, Ukraine, but was sent to practice
in Kurgan Oblast in far Siberia, where conditions were
harsh and facilities resembled those of LMICs. There, in
the 1950’s, he developed a piece of “meccano” which
resembled a tubular structure with pins attached [11].
Following small skin incisions, these pins are inserted into
intact bone on both sides of a fracture, allowing the exter-
nal structure to hold and stabilize bone alignment.
Known now as an external fixator, it has become one ofthe mainstays of operative fracture treatment [12]. This
technique permits minimal interference to blood supply
of the bone, direct observation of the wound, ability to
monitor and debride an open fracture as necessary with-
out losing stabilization, and is simply and rapidly applied
non-traumatically [13-15]. External fixation is recom-
mended in cases of open or closed articular fracture with
severe soft-tissue compromise, when the external fixator
can be applied in a joint-bridging fashion [16]. It is ideal
where there is a higher risk of infection and has long been
a useful device for managing such injuries and remains
the gold standard. In closed fractures, external fixation is
indicated for temporary bridging in severe polytrauma
[17,18] and severe closed soft-tissue contusions or deglov-
ing injury.
It was only in the late 1980s that Ilizarov traveled to
the US to speak of his invention, which was largely
unknown till then. Since then, the use of the external
fixator has found its place in the armamentarium of
every orthopaedic surgeon. External fixators cost be-
tween US$1,000 and US$4,000 [19]. Reuse of an external
fixator can reduce the mean hospital cost by 25% [20] to
34% [21]. The versatility of this device has spawned
local production: an Indian external fixator costs only
c. US$12 [22]. Sadly, Ilizarov himself gained little finan-
cially from his innovation [23].
Hydrocephalus drainage uni-directional fluid valve
Dr Salomón Hakim was a Colombian neurosurgeon who
studied normal-pressure hydrocephalus (NPH), a condition
that was previously thought not to exist. He first identified
the syndrome in 1957 and, in his workshop at his home in
Bogotá, Colombia, produced a functioning uni-directional
valve to drain the accumulated cerebrospinal fluid (CSF)
that occurs in affected patients. The valve unit has
entrance and exit valves respectively, utilizing a corrugated
or convoluted spring element for biasing a trapped ball
against a fluid inlet seat of the valve. He finally pub-
lished his work in 1964 and demonstrated the successful
treatment of a patient in the USA using his device [24].
Subsequent modern ventriculo-peritoneal shunts for the
drainage of CSF, including programmable and self-
adjusting types, have been based on the “standard
Hakim mechanism” [25]. The modern Codman-Hakim
Micro Precision Valve shunt system costs US$650.
However, the Indian company Surgiwear produces the
Chhabra Micro Precision shunt system for only US$35.
A study of hydrocephalic children in Uganda found
these two ventriculoperitoneal shunt systems equally
effective [26].
Intra-ocular lens & manual small incision cataract surgery
Growing up in a remote mountain village in the Northeast
of Nepal where the nearest school was a 12 days’ walk
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mined to qualify as an eye surgeon, he remained moti-
vated to help improve the eyesight of over 50 million
people in LMICs suffering with moderate to severe vis-
ual loss from cataract. The standard procedure, current
at the time, of cataract extraction and provision of +10
lenses gave poor results, and the technique of intra-
ocular lens (IOL) implantation, used in HICs, which
involved phaco-emulsification by a special instrument
and the implantation of an artificial lens, was very
expensive. Dr Ruit realized that an alternative was
needed. In 1986, he and an Australasian ophthalmologist,
Dr Fred Hollows, made highly effective cataract surgery
affordable to the poor. They developed ‘Small Incision
Cataract Surgery’ (SICS), a suture-free technique that
avoids phaco-emulsification and removes a cataract
through two very small incisions. Furthermore, in 1995,
Dr.Ruit also began to produce an international standard
IOL locally with drastically lower production costs that
reduced its purchasing price from US$100 to US$3.50c
[27]. Studies have found SICS to be “significantly fas-
ter, less expensive, and less technology dependent than
phaco-emulsification” [28]. While both achieve excel-
lent outcomes with minimal complications, SICS can
cope better with higher patient volumes and outpatient
care [29].
Mosquito net mesh for inguinal hernia repair
The Lichtenstein tension-free method of inguinal hernia
repair has been shown in studies in many countries to
be preferable in providing better outcomes in compari-
son to other previously popular techniques, such as the
Bassini method [30,31]. Yet, while it may be preferable,
the Lichtenstein method requires the insertion of a small
piece of non-absorbable mesh to bolster the hernia de-
fect. At over US$108 per patient, commercially produced
mesh is unaffordable for the majority of hernia patients
living in LMICs [32]. Fine nylon mesh, originally used in
the manufacture of fancy shoes in Hong Kong, was actu-
ally already proposed as an implant by Stock in 1954
[33]. In many LMICs, the manufacture, sale and use of
protective mosquito netting is ubiquitous. Tongaonkar
and colleagues, rural surgeons in India, validated its use
for hernia repair in an excellent 5-year follow-up study
[34]. Their innovation was studied in a randomized con-
trolled trial in Burkina Faso [32], which showed no
significant difference in the clinical short-term outcome
of both types of mesh, with the mosquito net costing
0.004% of the commercially-available mesh. When mos-
quito net mesh is used, tension-free inguinal hernia
repair is approximately one third the cost compared to
the use of the conventional alternative [35]. This has been
confirmed by a meta-analysis, which also demonstrated
no increase in septic complications [36]. Subsequentstudies have suggested that mosquito nets might actually
be better in terms of bursting strength and anisotropy
than commercial products in terms of retraction of the
mesh [37].
Flutter valve for intercostal drainage
The flutter valve is a one-way valve that can be used to
allow air or fluid to drain out of the thorax in cases of
hemo- or pneumo-thorax [38], without air being drawn
back into the pleural cavity on normal breathing. The use-
fulness of this was realized through experience in Karachi,
Pakistan and tested in London [39]. An early report had
already realized its usefulness in the war scenario, allowing
a patient to ambulate freely [40]. This, costing less than
US$5 [41], prevents both pneumostasis and the hazards of
breakable bottles, as well as the expense of complex drain-
age systems, at least ten times as expensive as a sterilized
flutter valve. Additionally, after lung reduction surgery,
the flutter valve is used to treat prolonged air leaks with-
out the potentially damaging effect of suction on a
severely emphysematous lung [42], and is more effective
in dealing with postoperative air leaks when there is no
persistent pleural space [43]. Also in cases of pneumocystis
carinii-related pneumothorax, it is very useful [44]. The
cost-effectiveness and practicality of the flutter valve is
largely the result of needing a less invasive procedure that
permits outpatient treatment and shortened hospital stays
[45,46]. Campisi and Voitk found outpatient care for
spontaneous pneumothorax alone saved one Canadian
hospital more than US$16,000 in the 1993–1994 fiscal
year [47].
Conclusions
Meeting the medical needs of large numbers of people,
many with little or no resources, is a moral obligation. To
satisfy this demand, simplicity of care is an obvious advan-
tage. Medical technology has enabled unimagined advances,
but often at great cost financially. In the circumstances
where such technology is unavailable or unaffordable, inno-
vations proliferate. Consequently, technology is produced
that is not only simpler (and therefore usually less expen-
sive), but that is more appropriate to the local environment.
The realization is dawning that the criterion of simplicity
may actually be advantageous in high-income countries
(HICs), not just because the maintenance of expensive
technology is in itself complex, and financially draining, but
because if a simple device is as good as a complicated one,
then the financial savings made are hugely relevant. Fur-
thermore, if a simple device is more robust and easier to
use, and is more effective clinically, then again its advantage
is evident.
As we have seen in the surgical world, innovations de-
veloped for and implemented in LMICs are usually far
less costly than those techniques and technologies that
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can occur anywhere, there exists much original think-
ing and spontaneous inventiveness amongst many
people grappling in sub-optimal environments. The
Global Surgical community of surgeons, anesthesiologists,
obstetricians, nurses, and administrators alike should
actively search for and validate the efficacy of innovations
introduced in LMICs, push for the acceptance of these
methods and campaign with ferocity for the financial gains
of innovations from LMICs to benefit those who have
invented and pioneered them. This means, in particular,
that healthcare providers from HICs traveling to LMICs
to provide medical care should be open and responsive to
the technology present before assuming the superiority of
developed world technologies in every setting.
Interested institutions in HICs may provide start-up
finance for potentially useful developments and contribute
to research into their efficacy prior to establishing clinical
trials to prove their worth. For this to happen, a forum for
sharing ideas needs to be created, but unless the benefits
of such innovations developed are to remain in HICs, this
forum must arise within LMICs.
Important, innovative methods and devices have the
potential to improve outcomes in both HICs and LMICs,
and demonstrate significant cost-savings in the setting of
ever-increasing costs of healthcare. In resource-limited
settings these cost savings translate immediately to lives
saved, because cost is a major barrier to treatment. In
HICs, however, the impact of ever-increasing costs of
medical care must ultimately drive the search for simpler,
but equally effective, technologies.
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